These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 7622910

  • 21. Concentrations of soluble tumor necrosis factor and interleukin-6 receptors in heatstroke and heatstress.
    Hammami MM, Bouchama A, Al-Sedairy S, Shail E, AlOhaly Y, Mohamed GE.
    Crit Care Med; 1997 Aug; 25(8):1314-9. PubMed ID: 9267943
    [Abstract] [Full Text] [Related]

  • 22. Endogenous modulators of TNF and IL-1 response are under partial control of TNF in baboon bacteremia.
    Redl H, Schlag G, Paul E, Bahrami S, Buurman WA, Strieter RM, Kunkel SL, Davies J, Foulkes R.
    Am J Physiol; 1996 Nov; 271(5 Pt 2):R1193-8. PubMed ID: 8945953
    [Abstract] [Full Text] [Related]

  • 23. A specific receptor antagonist for interleukin 1 prevents Escherichia coli-induced shock in rabbits.
    Wakabayashi G, Gelfand JA, Burke JF, Thompson RC, Dinarello CA.
    FASEB J; 1991 Mar 01; 5(3):338-43. PubMed ID: 1825816
    [Abstract] [Full Text] [Related]

  • 24. Plasma concentration of cytokine antagonists in patients with infection following liver resection.
    Kimura F, Miyazaki M, Suwa T, Sugiura T, Shinoda T, Itoh H, Ambiru S, Shimizu H, Nakagawa K.
    Br J Surg; 1998 Dec 01; 85(12):1631-5. PubMed ID: 9876064
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections.
    van Deuren M, van der Ven-Jongekrijg J, Demacker PN, Bartelink AK, van Dalen R, Sauerwein RW, Gallati H, Vannice JL, van der Meer JW.
    J Infect Dis; 1994 Jan 01; 169(1):157-61. PubMed ID: 8277177
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Interleukin-1, TNF alpha and their naturally occurring antagonists in sepsis.
    Moldawer LL.
    Blood Purif; 1993 Jan 01; 11(2):128-33. PubMed ID: 8274244
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Anti-inflammatory cytokine levels in patients with septic shock.
    Kasai T, Inada K, Takakuwa T, Yamada Y, Inoue Y, Shimamura T, Taniguchi S, Sato S, Wakabayashi G, Endo S.
    Res Commun Mol Pathol Pharmacol; 1997 Oct 01; 98(1):34-42. PubMed ID: 9434313
    [Abstract] [Full Text] [Related]

  • 36. Interleukin-1 and tumor necrosis factor and their naturally occurring antagonists during hemodialysis.
    Dinarello CA.
    Kidney Int Suppl; 1992 Oct 01; 38():S68-77. PubMed ID: 1328757
    [Abstract] [Full Text] [Related]

  • 37. Plasma and urinary cytokine homeostasis and renal function during cardiac surgery without cardiopulmonary bypass.
    Gormley SM, McBride WT, Armstrong MA, McClean E, MacGowan SW, Campalani G, McMurray TJ.
    Cytokine; 2002 Jan 21; 17(2):61-5. PubMed ID: 11886172
    [Abstract] [Full Text] [Related]

  • 38. Proinflammatory cytokine inhibitors, TNF-alpha and oxidative burst of polymorphonuclear leukocytes in the pathogenesis of sepsis in newborns.
    Sikora JP, Chlebna-Sokół D, Dabrowska I, Lipczyński D, Chrul S.
    Arch Immunol Ther Exp (Warsz); 2001 Jan 21; 49(2):155-61. PubMed ID: 11348020
    [Abstract] [Full Text] [Related]

  • 39. Interleukin-1 beta induces interleukin-1 receptor antagonist and tumor necrosis factor binding protein in humans.
    Bargetzi MJ, Lantz M, Smith CG, Torti FM, Olsson I, Eisenberg SP, Starnes HF.
    Cancer Res; 1993 Sep 01; 53(17):4010-3. PubMed ID: 8395334
    [Abstract] [Full Text] [Related]

  • 40. Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis.
    Muzaffer MA, Dayer JM, Feldman BM, Pruzanski W, Roux-Lombard P, Schneider R, Laxer RM, Silverman ED.
    J Rheumatol; 2002 May 01; 29(5):1071-8. PubMed ID: 12022325
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.